| Financial Year |
March 31 2023 |
| Monetary Funds |
674,423,985.20 |
| Held-for-trading Financial Assets |
31,772,593.90 |
| Notes Receivable |
140,697,177.82 |
| Accounts Receivable |
784,298,631.12 |
| Advances to Suppliers |
159,278,403.04 |
| Other Receivables |
120,079,517.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
92,163,455.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,546,221.41 |
| Other Current Assets |
56,304,761.56 |
| Total Current Assets |
2,073,670,273.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,887,741.08 |
| Investment Properties |
133,539,652.82 |
| Fixed Assetes |
485,692,402.55 |
| Under-construction Projects |
24,926,295.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
158,337,633.44 |
| R&D expenses |
-- |
| Goodwill |
18,253,625.22 |
| Long-Term Deferred and Prepaid Expenses |
45,841,154.87 |
| Deferred Income Tax Assets |
14,022,666.40 |
| Other Non-Current Assets |
10,898,411.54 |
| Sub-Total of Non-Current Assets |
1,504,124,255.72 |
| Total Assets |
3,577,794,528.88 |
| Short-Term Loans |
687,827,191.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
491,901,787.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,004,309.80 |
| Taxes Payable |
12,086,939.70 |
| Interest Payable |
-- |
| Dividend Payable |
224,300.00 |
| Other payables |
71,105,183.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
88,727,679.97 |
| Other Current Liabilities |
37,303,152.24 |
| Sub-Total of Current Liabilities |
1,474,268,688.61 |
| Long-term Loans |
116,400,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,122,999.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
7,000,000.00 |
| Deferred Income Tax Liabilities |
28,806,092.20 |
| Other Non-Current Liabilities |
21,679,192.93 |
| Sub-Total of Non-Current Liabilities |
396,134,460.96 |
| Total Liabilities |
1,870,403,149.57 |
| Paid-In Capital(Or Share Stock) |
369,992,000.00 |
| Capital Surplus |
225,099,289.75 |
| Surplus Reserve |
46,506,855.78 |
| LESS:Treasury Stock |
18,323,087.40 |
| Undistributed Profits |
729,949,498.16 |
| Minority Stockholder's Interest |
244,087,234.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,463,304,144.65 |
| Owner's Equity（Stockholder's Equity） |
1,707,391,379.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,577,794,528.88 |
